Acrivon Therapeutics sets 2023 annual meeting for June 22, 2023

Acrivon Therapeutics, Inc.

First annual meeting of stockholders scheduled for June 22, 2023.
Rule 14a-8 stockholder proposals must be received by March 13, 2023.
Advance notice for director nominations and other proposals due by March 17, 2023.

item 8.01

Acrivon Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-060173

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.